ADiTx Therapeutics logo
ADiTx Therapeutics ADTX
report update icon

Quarterly report 2026-Q1
added 11-21-2026

ADiTx Therapeutics Operating Cash Flow | ADTX

Annual Operating Cash Flow ADiTx Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-25.7 M -16.8 M -19.2 M -22.4 M -22.3 M -7.22 M -464 K - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-464 K -25.7 M -16.3 M

Quarterly Operating Cash Flow ADiTx Therapeutics

2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-4.58 M -9.25 M -2.34 M -2.38 M -11.7 M - -2.36 M -2.29 M -5.96 M -3.94 M -8.03 M -3.28 M -3.95 M -6.72 M -7.82 M -2.65 M -5.2 M -8.69 M -4.53 M -5.01 M -4.05 M -3.15 M -4.07 M -406 K -251 K - -415 K -309 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-251 K -11.7 M -4.36 M

Operating Cash Flow of other stocks in the Biotechnology industry

Issuer Operating Cash Flow Price % 24h Market Cap Country
Praxis Precision Medicines Praxis Precision Medicines
PRAX
-249 M $ 300.01 -3.5 % $ 6.75 B usaUSA
Prelude Therapeutics Incorporated Prelude Therapeutics Incorporated
PRLD
-56.3 M $ 3.22 -1.08 % $ 248 M usaUSA
ProQR Therapeutics N.V. ProQR Therapeutics N.V.
PRQR
-52.8 M $ 1.02 -2.38 % $ 107 M niderlandNiderland
Ocular Therapeutix Ocular Therapeutix
OCUL
-205 M $ 5.57 -5.03 % $ 1.04 B usaUSA
Sana Biotechnology Sana Biotechnology
SANA
-144 M $ 1.58 -9.2 % $ 400 M usaUSA
Outlook Therapeutics Outlook Therapeutics
OTLK
-51.8 M $ 0.39 -2.79 % $ 13.6 M usaUSA
uniQure N.V. uniQure N.V.
QURE
-178 M $ 19.32 -4.5 % $ 1.11 B niderlandNiderland
Ultragenyx Pharmaceutical Ultragenyx Pharmaceutical
RARE
-466 M $ 16.46 -4.41 % $ 1.62 B usaUSA
Rafael Holdings Rafael Holdings
RFL
-30 M $ 0.94 5.89 % $ 48.3 M usaUSA
REGENXBIO REGENXBIO
RGNX
-124 M $ 7.16 -0.35 % $ 369 M usaUSA
Rigel Pharmaceuticals Rigel Pharmaceuticals
RIGL
75.7 M $ 40.05 -2.78 % $ 720 M usaUSA
Celsion Corporation Celsion Corporation
CLSN
-13.9 M - -6.63 % $ 13.9 M usaUSA
I-Mab I-Mab
IMAB
-1.3 B - - $ 866 M chinaChina
Tenax Therapeutics Tenax Therapeutics
TENX
-35.8 M $ 1.27 -8.27 % $ 49.8 M usaUSA
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
VRTX
3.63 B $ 514.68 -1.15 % $ 132 B usaUSA
Genfit SA Genfit SA
GNFT
15.5 M - 2.54 % $ 160 B franceFrance
Biophytis SA Biophytis SA
BPTS
-12.9 M - -13.47 % $ 169 M franceFrance
SELLAS Life Sciences Group SELLAS Life Sciences Group
SLS
-28.4 M $ 13.67 -8.01 % $ 1.49 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
102 M - - $ 867 M germanyGermany
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.
BVXV
-24.5 M - 0.74 % $ 768 M israelIsrael
Abcam plc Abcam plc
ABCM
28.7 M - - $ 4.9 B britainBritain
Rezolute Rezolute
RZLT
-64.6 M $ 3.92 -6.69 % $ 407 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-5.59 M - -18.52 % $ 27.3 M britainBritain
Tiziana Life Sciences PLC Tiziana Life Sciences PLC
TLSA
-1.53 M $ 0.63 -7.05 % $ 67.2 M britainBritain
MorphoSys AG MorphoSys AG
MOR
-296 M - 2.43 % $ 254 M germanyGermany
Affimed N.V. Affimed N.V.
AFMD
-110 M - -34.95 % $ 21.5 M germanyGermany
AnPac Bio-Medical Science Co., Ltd. AnPac Bio-Medical Science Co., Ltd.
ANPC
-55.1 M - -1.58 % $ 28.1 M chinaChina
Celyad Oncology SA Celyad Oncology SA
CYAD
-28 M - - $ 12.5 M belgiumBelgium
Seer Seer
SEER
-44.4 M $ 1.34 -3.25 % $ 74.5 M usaUSA
Gracell Biotechnologies Gracell Biotechnologies
GRCL
-483 M - - $ 3.37 B chinaChina
Summit Therapeutics Summit Therapeutics
SMMT
-323 M $ 9.94 -6.01 % $ 7.43 B britainBritain
Shattuck Labs Shattuck Labs
STTK
-39.9 M $ 4.49 -1.43 % $ 312 M usaUSA
Silence Therapeutics plc Silence Therapeutics plc
SLN
-39.4 M $ 19.81 0.08 % $ 2.81 B britainBritain
Soligenix Soligenix
SNGX
-10.3 M $ 0.22 -8.25 % $ 1.14 M usaUSA
Sanofi Sanofi
SNY
10.8 B $ 46.51 0.97 % $ 56.8 B franceFrance
Spruce Biosciences Spruce Biosciences
SPRB
-33.3 M $ 38.02 -6.11 % $ 29.1 M usaUSA
Spero Therapeutics Spero Therapeutics
SPRO
-12.6 M $ 0.74 -10.95 % $ 41.5 M usaUSA
Sarepta Therapeutics Sarepta Therapeutics
SRPT
-205 M $ 13.34 -5.86 % $ 1.34 B usaUSA
Savara Savara
SVRA
-101 M $ 4.28 -17.95 % $ 952 M usaUSA
Sutro Biopharma Sutro Biopharma
STRO
-177 M $ 8.6 -1.38 % $ 73.1 M usaUSA
Tarsus Pharmaceuticals Tarsus Pharmaceuticals
TARS
-12.5 M $ 72.94 -6.09 % $ 3.05 B usaUSA
Supernus Pharmaceuticals Supernus Pharmaceuticals
SUPN
47.3 M $ 36.28 1.88 % $ 2.05 B usaUSA
TG Therapeutics TG Therapeutics
TGTX
-24.8 M $ 63.39 -2.3 % $ 9.15 B usaUSA
Viridian Therapeutics Viridian Therapeutics
VRDN
-276 M $ 29.91 -4.87 % $ 3.05 B usaUSA
Trevi Therapeutics Trevi Therapeutics
TRVI
-42.1 M $ 13.35 -2.73 % $ 1.8 B usaUSA